ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Spectral Decomposition of Chemical Semantics for Activity Cliffs-Aware Molecular Property Prediction.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Task-adaptive multimodal molecular representations for structure-sensitive property prediction.Chemical science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Accurately predicting physicochemical and biological properties of molecules is vital for modern drug discovery, yet existing deep learning models struggle to replicate the multi-level reasoning of chemists. Relying on single molecular graphs, they fail to capture the interplay among global scaffolds, functional groups, and pharmacophoric patterns, and often miss subtle perturbations causing "activity cliffs". PrismNet is proposed as a spectral graph network that mimics chemical intuition through a computational prism analogy. It applies a dual-decomposition strategy: refracting molecules into three chemical perspectives-scaffolds, functional groups, and pharmacophores-and resolving each into spectral frequencies. A dynamic learning strategy further enhances its ability to handle heterogeneous data. PrismNet achieves state-of-the-art performance across 64 benchmark datasets, including 30 activity cliff datasets. Importantly, its predictions are chemically interpretable, autonomously identifying key substructures aligned with known structure-activity relationships. This framework unifies multi-scale semantics and spectral decomposition, enabling reliable and trustworthy in silico screening for drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.